Development asset linked to Chiesi Farmaceutici S.p.A in public FDA and regional records.
pharma · COPD (Chronic Obstructive Pulmonary Disease) · Uncontrolled Asthma
Chiesi Farmaceutici S.p.A
Chiesi Farmaceutici S.p.A.
Chiesi Farmaceutici S.p.A drug portfolio — 3 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Parma, IT HQ
6,080 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Parma, IT
- Employees
- 6,080
- Programs
- 2
- Drugs
- 3
- Patents
- 0
Chiesi Farmaceutici S.p.A pipeline
Portfolio lens on 3 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Chiesi Farmaceutici S.p.A drug portfolio — 3 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Chiesi Farmaceutici S.p.A in public FDA and regional records.
-
Development asset linked to Chiesi Farmaceutici S.p.A in public FDA and regional records.